Amcor's Bloom Biorenewables secures $14 million Series A Funding
Bloom has pioneered a technology to transform plant waste into valuable chemical products
Bloom has pioneered a technology to transform plant waste into valuable chemical products
The funding round also saw participation from some of India's top angel investors and leading industry giants
The company plans to invest in technology, business development, product innovation, and development across India
The financing secures funds to advance the clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April, through Phase IIa, targeting COPD as a primary indication
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
ALV-100 is a bifunctional fusion protein combining glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonism with glucagon-like peptide-1 receptor agonism
NTX-253 is a potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor
The freshly infused capital will primarily be deployed towards expansion and research & development
A funding to expand operations and provide better patient care
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Subscribe To Our Newsletter & Stay Updated